DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zometa (Zoledronic Acid) - Current Clinical Trials

 
 



Zometa Related Clinical Trials

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer [Active, not recruiting]

Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis [Completed]

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer [Completed]

Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Completed]

Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer [Terminated]

ZOMETA« (Zoledronic Acid) for Prevention of Bone Metastases [Terminated]

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer [Terminated]

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer [Completed]

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) [Active, not recruiting]

Pre-operative Zoledronate in Triple Negative Breast Cancer [Recruiting]

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer [Completed]

The Use of Zoledronic Acid to Complex Regional Pain Syndrome [Not yet recruiting]

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer [Completed]

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer [Completed]

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Completed]

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Completed]

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate [Completed]

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone [Completed]

To Evaluate the Efficacy of ZOMETA« in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Completed]

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid [Active, not recruiting]

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis [Active, not recruiting]

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Terminated]

Zoledronic Acid Administration in Acute Spinal Cord Injury [Completed]

A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) [Completed]

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy [Completed]

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Completed]

Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) [Completed]

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement [Completed]

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis [Completed]

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy [Completed]

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast« [Completed]

A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) [Completed]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Completed]

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) [Completed]

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer [Completed]

Zoledronate for Osteopenia in Pediatric Crohn's [Completed]

Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients [Active, not recruiting]

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year [Completed]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Completed]

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer [Active, not recruiting]

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma [Completed]

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer [Not yet recruiting]

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions [Completed]

Zoledronic Acid in Acute Spinal Cord Injury [Recruiting]

The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP) [Completed]

Efficacy and Safety Study of ZOMETA« in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Completed]

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer [Terminated]

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy [Completed]

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma [Completed]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Completed]

Zoledronate With Atorvastatin in Renal Cell Carcinoma [Completed]

Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy [Completed]

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation [Recruiting]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer [Completed]

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) [Terminated]

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients [Completed]

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer [Terminated]

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant [Completed]

An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta [Active, not recruiting]

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women [Completed]

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer [Completed]

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. [Completed]

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma [Active, not recruiting]

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis [Completed]

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria [Completed]

Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma [Recruiting]

Re-treatment of Patients With Paget's Disease Using Zoledronic Acid [Completed]

Bone Loss Treatment From Adjuvant Zoledronate Efficacy [Recruiting]

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Active, not recruiting]

A Multiple Myeloma Trial in Patients With Bone Metastases [Completed]

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss [Active, not recruiting]

Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma [Terminated]

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions [Completed]

Zoledronic Acid in MS-patients With Osteoporosis [Terminated]

Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma [Completed]

Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma [Completed]

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases [Completed]

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer [Active, not recruiting]

Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients [Recruiting]

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer [Active, not recruiting]

Zoledronic Acid in Rheumatoid Arthritis [Recruiting]

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Completed]

Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older [Completed]

The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta [Recruiting]

Phase 1 Study of Zoledronic Acid in Sickle Cell Disease [Withdrawn]

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole [Completed]

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis [Completed]

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid [Not yet recruiting]

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I [Terminated]

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. [Completed]

Prevention of Bone Loss After Acute SCI by Zoledronic Acid [Recruiting]

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort [Completed]

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015